Telemedicine

Telemedicine Solutions Help Rural Hospitals Boost Revenue, Cut Transfers, and Improve Care Access

Telemedicine Boosts Rural Hospitals’ Revenue and Care Access Rural healthcare in the United States is at a pivotal moment. Nearly one in five Americans—more than 60 million people—live in rural communities, where access to high-quality, specialized medical care remains a…

Read MoreTelemedicine Solutions Help Rural Hospitals Boost Revenue, Cut Transfers, and Improve Care Access
Carna

Carna Health Named to Fortune’s 2026 List of America’s Most Innovative Companies

Carna Health Named to Fortune’s 2026 List of America’s Most Innovative Companies Carna Health, a pioneering digital health company focused on transforming kidney care and addressing cardio-kidney metabolic (CKM) conditions, has earned a place on Fortune’s prestigious list of America’s…

Read MoreCarna Health Named to Fortune’s 2026 List of America’s Most Innovative Companies
CompHealth

CompHealth Earns Joint Commission Recognition for Quality & Safety

CompHealth Earns Joint Commission Certification, Reinforcing Commitment to Quality and Safety in Healthcare Staffing CompHealth, a leading provider of healthcare staffing solutions specializing in advanced practice, therapy, and laboratory services, has achieved the prestigious Health Care Staffing Services (HCSS) Certification…

Read MoreCompHealth Earns Joint Commission Recognition for Quality & Safety
FDA

FDA Approves Corcept’s Lifyorli™ Combo for Platinum-Resistant Ovarian Cancer

U.S. Food and Drug Administration Approves Corcept’s Lifyorli™ (relacorilant) Combination Therapy for Platinum-Resistant Ovarian Cancer Corcept Therapeutics Incorporated has announced a major regulatory milestone with the approval of its novel therapy, Lifyorli™ (relacorilant), by the U.S. Food and Drug Administration.…

Read MoreFDA Approves Corcept’s Lifyorli™ Combo for Platinum-Resistant Ovarian Cancer

Seaport Therapeutics Publishes Science Translational Medicine Study on GlyphAllo™ (SPT-300) Prodrug

PureTech Founded Entity Seaport Therapeutics Publishes First-in-Human Data on GlyphAllo™ (SPT-300) in Science Translational Medicine PureTech Health plc a biotherapeutics company focused on advancing innovative science into impactful medicines, announced that its Founded Entity, Seaport Therapeutics, has published significant clinical…

Read MoreSeaport Therapeutics Publishes Science Translational Medicine Study on GlyphAllo™ (SPT-300) Prodrug
Imperative

Imperative Care Starts CLEAR-IT Study for Peripheral Thromboembolism Standards

Imperative Care Launches CLEAR-IT Study to Advance Standards in Peripheral Thromboembolism Imperative Care, Inc., a medical technology company dedicated to advancing innovative treatments for patients with thromboembolic diseases, has announced a significant milestone in its ongoing clinical research efforts: the…

Read MoreImperative Care Starts CLEAR-IT Study for Peripheral Thromboembolism Standards